Guillain-Barre Syndrome - Postprocedure

9/28/00 (Franco)

Question: What is the association between Guillain-Barre syndrome and diagnostic and/or operative procedures?

<11>

Unique Identifier: 96431986 / PubMed Identifier: 8835052

Authors: Awong IE. Dandurand KR. Keeys CA. Maung-Gyi FA.

Institution: Clinical Pharmacy Associates, Beltsville, MD 20705, USA.

Abstract: OBJECTIVE: To present an overview of reported drug-associated Guillain-Barre syndrome (GBS) and current management of the disease. DATA SOURCES: Case reports and reviews of drug-associated GBS published in the English-language literature from 1982 through 1994 were retrieved from MEDLINE. An additional search was done through the Iowa Drug Information System for the same period. This search yielded incidents that occurred as early as 1976. The key search terms were GBS, polyneuropathy, chemically induced polyradiculoneuropathy, and etiology of GBS. The searches were limited to human subjects. DATA SYNTHESIS: Drugs that have been associated with GBS are presented, and although no definite relationships have been established, selected reports attempt to show an increased incidence of GBS after drug therapy. Outcome of medical management of GBS has been variable; however, death occurs in less than 10% of those affected. CONCLUSIONS: GBS and clinically similar states have been reported to occur with a variety of drugs and biologics; however, because of the paucity of available data a well-defined cause and effect relationship has not been established between GBS and any drug. There appears to be no treatment of choice for this disorder. Further comparative studies should be done to determine the therapy with the most consistent outcome. [References: 43]

<17>

Unique Identifier: 90223144 / PubMed Identifier: 2326697

Authors: Stambough JL. Quinlan JG. Swanson JD.

Institution: Department of Orthopaedic Surgery, University of Cincinnati Medical Center, Ohio.

<19>

Unique Identifier: 81020719 / PubMed Identifier: 7417062

Authors: Kelley RE. Daroff RB. Sheremata WA. McCormick JR.

Abstract: A clinical constellation of aseptic meningitis, arachnoiditis, communicating hydrocephalus, and a Guillain-Barre syndrome occurred following lumbar myelography with metrizamide. To our knowledge, Guillain-Barre syndrome has not been previously described following myelography with any contrast agent. Meningeal reactions and hydrocephalus have been reported with other agents, but this is the first instance with metrizamide.

<20>

Unique Identifier: 73042547 / PubMed Identifier: 4508222

Authors: Shuert GT. Gamble JW.